Identificador persistente para citar o vincular este elemento:
http://hdl.handle.net/10553/47716
Campo DC | Valor | idioma |
---|---|---|
dc.contributor.author | Clavo, Bernardino | en_US |
dc.contributor.author | Santana Rodríguez, Norberto | en_US |
dc.contributor.author | Llontop, Pedro | en_US |
dc.contributor.author | Gutierrez, Dominga | en_US |
dc.contributor.author | Ceballos Santos, Daniel Sebastián | en_US |
dc.contributor.author | Méndez, Charlin | en_US |
dc.contributor.author | Rovira, Gloria | en_US |
dc.contributor.author | Suarez, Gerardo | en_US |
dc.contributor.author | Rey-Baltar, Dolores | en_US |
dc.contributor.author | Garcia-Cabrera, Laura | en_US |
dc.contributor.author | Martínez-Sánchez, Gregorio | en_US |
dc.contributor.author | Fiuza, Dolores | en_US |
dc.date.accessioned | 2018-11-23T15:49:35Z | - |
dc.date.available | 2018-11-23T15:49:35Z | - |
dc.date.issued | 2015 | en_US |
dc.identifier.issn | 1741-427X | en_US |
dc.identifier.uri | http://hdl.handle.net/10553/47716 | - |
dc.description.abstract | Introduction. Persistent radiation-induced proctitis and rectal bleeding are debilitating complications with limited therapeutic options. We present our experience with ozone therapy in the management of such refractory rectal bleeding. Methods. Patients () previously irradiated for prostate cancer with persistent or severe rectal bleeding without response to conventional treatment were enrolled to receive ozone therapy via rectal insufflations and/or topical application of ozonized-oil. Ten (83%) patients had Grade 3 or Grade 4 toxicity. Median follow-up after ozone therapy was 104 months (range: 52–119). Results. Following ozone therapy, the median grade of toxicity improved from 3 to 1 () and the number of endoscopy treatments from 37 to 4 (). Hemoglobin levels changed from 11.1 (7–14) g/dL to 13 (10–15) g/dL, before and after ozone therapy, respectively (). Ozone therapy was well tolerated and no adverse effects were noted, except soft and temporary flatulence for some hours after each session. Conclusions. Ozone therapy was effective in radiation-induced rectal bleeding in prostate cancer patients without serious adverse events. It proved useful in the management of rectal bleeding and merits further evaluation. | en_US |
dc.language | eng | en_US |
dc.relation.ispartof | Evidence-Based Complementary and Alternative Medicine | en_US |
dc.source | Evidence-based Complementary and Alternative Medicine[ISSN 1741-427X],v. 2015 (480369) | en_US |
dc.subject | 32 Ciencias médicas | en_US |
dc.subject | 320101 Oncología | en_US |
dc.subject.other | Ozone therapy | en_US |
dc.subject.other | Prostate cancer | en_US |
dc.title | Ozone therapy in the management of persistent radiation-induced rectal bleeding in prostate cancer patients | en_US |
dc.type | info:eu-repo/semantics/article | en_US |
dc.type | Article | en_US |
dc.identifier.doi | 10.1155/2015/480369 | en_US |
dc.identifier.scopus | 2-s2.0-84940755024 | - |
dc.contributor.authorscopusid | 57190093030 | - |
dc.contributor.authorscopusid | 56072780900 | - |
dc.contributor.authorscopusid | 37041705700 | - |
dc.contributor.authorscopusid | 8616778800 | - |
dc.contributor.authorscopusid | 15834224200 | - |
dc.contributor.authorscopusid | 56816472500 | - |
dc.contributor.authorscopusid | 6506763433 | - |
dc.contributor.authorscopusid | 7101855600 | - |
dc.contributor.authorscopusid | 6505717937 | - |
dc.contributor.authorscopusid | 56386004800 | - |
dc.contributor.authorscopusid | 6603422480 | - |
dc.contributor.authorscopusid | 6506332517 | - |
dc.identifier.issue | 480369 | - |
dc.relation.volume | 2015 | en_US |
dc.investigacion | Ciencias de la Salud | en_US |
dc.type2 | Artículo | en_US |
dc.description.numberofpages | 7 | en_US |
dc.utils.revision | Sí | en_US |
dc.date.coverdate | Agosto 2015 | en_US |
dc.identifier.ulpgc | Sí | en_US |
dc.contributor.buulpgc | BU-MED | en_US |
dc.description.sjr | 0,77 | - |
dc.description.jcr | 1,931 | - |
dc.description.sjrq | Q1 | - |
dc.description.jcrq | Q2 | - |
dc.description.scie | SCIE | - |
item.grantfulltext | none | - |
item.fulltext | Sin texto completo | - |
crisitem.author.dept | GIR IUIBS: Farmacología Molecular y Traslacional | - |
crisitem.author.dept | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.dept | GIR IUIBS: Farmacología Molecular y Traslacional | - |
crisitem.author.dept | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.dept | Departamento de Ciencias Médicas y Quirúrgicas | - |
crisitem.author.orcid | 0000-0003-2522-1064 | - |
crisitem.author.orcid | 0000-0003-2384-4524 | - |
crisitem.author.parentorg | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.parentorg | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.fullName | Clavo Varas,Bernardino | - |
crisitem.author.fullName | Santana Rodríguez,Norberto | - |
crisitem.author.fullName | Ceballos Santos, Daniel Sebastián | - |
Colección: | Artículos |
Citas SCOPUSTM
19
actualizado el 15-dic-2024
Citas de WEB OF SCIENCETM
Citations
17
actualizado el 15-dic-2024
Visitas
119
actualizado el 23-nov-2024
Google ScholarTM
Verifica
Altmetric
Comparte
Exporta metadatos
Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.